Infectious Diseases
| Focus: | Infectious Diseases |
|---|---|
| Type: | database (supplied by e-mail as setup.exe file) |
| No. of deals: | 185 |
| No. of companies: | 157 |
| Years covered: | 1996 – 2011 |
| Price: | € 800 ex VAT (if applicable) |
| System requirements: | Windows 2000/Windows XP/Windows Vista/7 |
| Publisher: | PharmaPlus Consultancy B.V. |
Are you about to enter deal negotiations for your infectious diseases therapeutic?
Use PharmaDeal Financials Infectious Diseases to benchmark your next deal for your infectious diseases product
PharmaDeal Financials Infectious Diseases
- Deal specifics on over 180 infectious diseases deals
- Deal making trends since 1996
- Deals from both big pharmalicensees like GlaxoSmithKline and Sanofi and regional licensees like Forest Laboratories, Sosei and Daewoong Pharmaceutical Co.
- 48% early stage deals
- 14% vaccine-related deals
- 62% exclusive worldwide deals
- Upfront payments from USD 0.25 million to USD 80 million for phase III products
- Total milestones from USD 3 million to USD 1.5 billion (worldwide licenses)
Each deal entry is categorized and searchable by licensor, licensee, indication, compound details, compound name, development stage (research-filed), geographical territory, potential deal size, upfront, total milestones-regulatory milestones-sales milestones payments, profit sharing, royalties on sales, research funding, equity and by year of deal establishment or any combination thereof.
Indications (selection)
Anthrax, bacterial infections, candidiasis, common cold, conjunctivitis, CMV infection, Dengue fever, diabetic foot infection, fungal infections, hepatitis B, hepatitis C, herpes, HIV, influenza, Japanese encephalitis, meningitis, onychomycosis, otitis media, pneumonia, RSV infection, skin and skin structure infections, viral infections, West Nile infection
Compound keywords (selection)
Aminoglycosides, aminomethylcyclines, antibodies, antisense, azoles, beta-lactamase inhibitors, boron-containing compounds, carbapenems, deformylase inhibitors, echinocandins, efflux pump inhibitors, entry inhibitors, fusion inhibitors, interferons, lipopeptides, macrolides, monobactams, neuramidase inhibitors, NNRTIs, NRTIs, nucleoside analogues, oxazolidinones, penems, penicillines, polymerase inhibitors, protease inhibitors, quinolones, RNA modulators (microRNA, RNAi), tetracycline derivatives, TLR-modulators, vaccines
Companies included in database
3M Co., Abbott Laboratories, Access Pharmaceuticals (MacroChem), Achillion Pharmaceuticals, Adventrx Pharmaceuticals, Aeolus Pharmaceuticals (Transcell Technologies), Aerogen, Agennix (GPC Biotech), Aileron Therapeutics, Akela Pharma (StressGen Biotechnologies Corporation), Alios BioPharma, Alnylam Pharmaceuticals, Alopexx Pharmaceuticals, AlphaVax, Ambrilia Biopharma, Anacor Pharmaceuticals, Anadys Pharmaceuticals (Scriptgen Pharmaceuticals), Antigenics (Aronex Pharmaceuticals), Apricus Biosciences (NexMed), Ardea Biosciences (IntraBiotics Pharmaceuticals), Astellas Pharma, AstraZeneca (Medimmune/Aviron,Novexel), Avexa, Axcan Pharma (Mpex Pharmaceuticals), Basilea Pharmaceutica, Baxter, Bayer, BioAlliance Pharma, BioCryst Pharmaceuticals, BioDiem, Biota Holdings, Boehringer Ingelheim, Bristol-Myers Squibb (DuPont Pharmaceuticals, Medarex), Bukwang Pharmaceutical Ind. Co., Cadence Pharmaceuticals (Strata Pharmaceuticals), Cantab Biopharmaceuticals, Cardiovascular Systems (Replidyne), Concert Pharmaceuticals, Cornerstone Therapeutics (Cornerstone BioPharma), Cubist Pharmaceuticals, Daiichi Sankyo (Ranbaxy Laboratories), Dainippon Sumitomo Pharma (Dainippon Pharmaceutical Co., Sumitomo), Danisco (Genencor International), Dong Wha Pharmaceutical Ind. Co., Dynavax Technologies Corporation, Elan Corporation, Eli Lilly & Company, Emergent Biosolutions, Emisphere Technologies, Enanta Pharmaceuticals, Endo Pharmaceuticals (Indevus Pharmaceuticals), Enzon Pharmaceuticals, Epiphany Biosciences, Extracta, Facet Biotech Corporation (Protein Design Labs), FOB Synthesis, Forest Laboratories, Galapagos (Biofocus DPI), Genaerea Corporation, GeneSoft Pharmaceuticals, Gilead Sciences (Triangle Pharmaceuticals), GlaxoSmithKline (GeneLabs Technologies, GlaxoWellcome, Reliant Pharmaceuticals, SmithKline Beecham), Hainan Noken Pharmaceutical Industry, Handok Pharmaceuticals Co., Human Genome Sciences, Idenix Pharmaceuticals (Novirio Pharmaceuticals), Idera Pharmaceuticals, Immtech Pharmaceuticals, Immune Design Corporation, Inovio Biomedical Corporation, Insite Vision, Intercell, Intermune, Isis Pharmaceuticals, Japan Energy Corporation, Japan Tobacco, Johnson & Johnson (Crucell (Acambis), Tibotec), Kadmon Pharmaceuticals, Karo Bio, Kuhnil Pharmaceutical Co., Kyowa Hakko Kirin Co (Kyowa Hakko), Leo Pharma, LFB Biotechnologies, LG Chemical, Lupin, MacroGenics, Maxygen, Medigene, Medivir, Merck & Co (Elitra Pharmaceuticals, Inspire Pharmaceuticals, Ribozyme Pharmaceuticals, Schering-Plough), Metabasis Therapeutics, MethylGene, MiddleBrook Pharmaceuticals (Advancis Pharmaceutical Corporation), Migenix (Micrologix Biotech), Mitsubishi Tanabe Pharma (Mitsubishi Pharma Corporation), NasVax (Protea Vaccine Technologies), NatImmune, Nektar Therapeutics, NicOx, Nobilon International, Novamed Pharmaceuticals, Novartis (Chiron/PathoGenesis Corporation), Oncolys Biopharma, Optimer Pharmaceuticals, Orchid Chemicals and Pharmaceuticals, Oscient Pharmaceuticals (Genome Therapeutics Corporation), Pacific Beach Biosciences, Par Pharmaceutical, Paratek Pharmaceuticals, Pfizer (Agouron Pharmaceuticals, Coley Pharmaceutical Group, Pharmacia & Upjohn, PowderJect Pharmaceuticals, Versicor, Vicuron Pharmaceuticals/BioSearch Italia, Wyeth, Wyeth-Ayerst), PharmaPlaz, Pharmasset, Phogen, PTC Therapeutics, Questcor Pharmaceuticals (RiboGene), Regulus Therapeutics, Rib-X Pharmaceuticals, Roche (Genentech), Samaritan Pharmaceuticals, Sanofi (Aventis-Pharma, Hoechst Marion Roussel, Pasteur Mérieux, Sanofi-Aventis, Sanofi-Pasteur/OraVax), Santaris Pharma, Sareum Holdings, Shionogi, Shire, Siga Pharmaceuticals, SkyePharma, Sosei, Stellar Pharmaceuticals, Symphogen, Synega BioPharma Corporation (Trimeris), Syntiron, Tacere Therapeutics, Takeda Pharmaceutical Company (IDM Pharma/Epimmune, Millennium Pharmaceuticals, Nycomed (Altana/Byk Gulden)), Teva Pharmaceutical Industries (Pliva), Thallion Pharmaceutials, The Althexis Company, The Immune Response Corporation, Theraclone Sciences, Theragenex, Theravance, Toyama Chemical Co, Trellis Bioscience, Trius Therapeutics, TTY Biopharm Company, Valeant Pharmaceuticals, Vaxgen, Verenium Corporation (Diversa Corporation), Vernalis (British Biotech), Vertex Pharmaceuticals, Vical, Viropharma, Vivalis, Xoma, XTL Biopharmaceuticals, Zenyaku Kogyo, Zephyr Sciences, ZymoGenetics
